Kezar Life Sciences Inc (NASDAQ: KZR) kicked off on Tuesday, down -4.39% from the previous trading day, before settling in for the closing price of $0.77. Over the past 52 weeks, KZR has traded in a range of $0.52-$1.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 12.44%. With a float of $62.06 million, this company’s outstanding shares have now reached $72.78 million.
The firm has a total of 58 workers. Let’s measure their productivity. In terms of profitability, gross margin is 31.36%, operating margin of -6332.12%, and the pretax margin is -6270.23%.
Kezar Life Sciences Inc (KZR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Kezar Life Sciences Inc is 14.94%, while institutional ownership is 50.34%. The most recent insider transaction that took place on Jul 02 ’24, was worth 3,879. In this transaction Chief Legal Officer of this company sold 6,688 shares at a rate of $0.58, taking the stock ownership to the 33,007 shares.
Kezar Life Sciences Inc (KZR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 12.44% per share during the next fiscal year.
Kezar Life Sciences Inc (NASDAQ: KZR) Trading Performance Indicators
Take a look at Kezar Life Sciences Inc’s (KZR) current performance indicators. Last quarter, stock had a quick ratio of 9.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.05 in one year’s time.
Technical Analysis of Kezar Life Sciences Inc (KZR)
Analysing the last 5-days average volume posted by the [Kezar Life Sciences Inc, KZR], we can find that recorded value of 2.11 million was better than the volume posted last year of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 73.68%. Additionally, its Average True Range was 0.06.
During the past 100 days, Kezar Life Sciences Inc’s (KZR) raw stochastic average was set at 64.70%, which indicates a significant increase from 64.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 152.46% in the past 14 days, which was higher than the 73.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6186, while its 200-day Moving Average is $0.7612. Now, the first resistance to watch is $0.7884. This is followed by the second major resistance level at $0.8367. The third major resistance level sits at $0.8629. If the price goes on to break the first support level at $0.7139, it is likely to go to the next support level at $0.6877. Now, if the price goes above the second support level, the third support stands at $0.6394.
Kezar Life Sciences Inc (NASDAQ: KZR) Key Stats
The company with the Market Capitalisation of 53.99 million has total of 72,801K Shares Outstanding. Its annual sales at the moment are 7,000 K in contrast with the sum of -101,870 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -21,550 K.
